Background: Since current therapies for depression are effective but not for all patients alike, we need to further improve available treatments. Existing research suggests that acceptance and commitment therapy (ACT) may effectively treat major depressive disorder (MDD). We compared ACT with cognitive behavioral therapy (CBT) for depression, testing the hypothesis that CBT would outperform ACT. Methods: We conducted a randomized controlled trial with 82 patients suffering from MDD. Data were collected before and after treatment and at the 6-month follow-up, assessing diagnosis, symptom levels of depression, and quality of life. Results: After treatment, the rates of remission from depression were 75 and 80% for the ACT and CBT conditions, respectively. Patients in both conditions further reported significant and large reductions in depressive symptoms and improvement in quality of life from before to after treatment as well as at the follow-up. Our findings indicated no significant differences between the two intervention groups. Conclusion: Our results indicate that CBT is not more effective in treating depression than ACT. Further research is needed to investigate whether ACT and CBT work differently for different groups of patients with depression.

Keywords:
Acceptance and commitment therapy, Cognitive behavioral therapy, Depression, Randomized controlled trial
1.
Hayes SC, Strosahl KD, Wilson KG: Acceptance and Commitment Therapy: The Process and Practice of Mindful Change, ed 2. New York, Guilford Press, 2012.
2.
Cuijpers P, Cristea IA, Karyotaki E, Reijnders M, Huibers MJH: How effective are cognitive behavior therapies for major depression and anxiety disorders? A meta-analytic update of the evidence. World Psychiatry 2016; 15: 245–258.
3.
DeRubeis R, Hollon SD, Amsterdam JD, Shelton RC, Young PR, Salomon RM, O’Reardon JP, Lovett ML, Gladis MM, Brown LL, Gallop R: Cognitive therapy vs medications in the treatment of moderate to severe depression. Arch Gen Psychiatry 2005; 62: 409–416.
4.
Vittengl JR, Clark LA, Dunn TW, Jarrett RB: Reducing relapse and recurrence in unipolar depression: a comparative meta-analysis of cognitive-behavioral therapy’s effects. J Consult Clin Psychol 2007; 73: 475–488.
5.
Bohlmeijer ET, Fledderus M, Rokx TA, Pie­terse ME: Efficacy of an early intervention based on acceptance and commitment therapy for adults with depressive symptomatology: evaluation in a randomized controlled trial. Behav Res Ther 2011; 49: 62–67.
6.
Folke F, Parling T, Melin L: Acceptance and commitment therapy for depression: a preliminary randomized clinical trial for unemployed on long-term sick leave. Cogn Behav Pract 2012; 19: 583–594.
7.
Gaudiano BA, Busch AM, Wenze SJ, Nowlan K, Epstein-Lubow G, Miller IW: Acceptance-based behavior therapy for depression with psychosis: results from a pilot feasibility randomized controlled trial. J Psychiatr Pract 2015; 21: 320–333.
8.
Hayes L, Boyd CP, Sewell J: Acceptance and commitment therapy for the treatment of adolescent depression: a pilot study in a psychiatric outpatient setting. Mindfulness 2011; 2: 86–94.
9.
Petersen CL, Zettle RD: Treating inpatients with comorbid depression and alcohol use disorders: a comparison of acceptance and commitment therapy versus treatment as usual. Psychol Rec 2009; 59: 521–536.
10.
Tamannaeifar S, Gharraee B, Birashk B, Habibi M: A comparative effectiveness of acceptance and commitment therapy and group cognitive therapy for major depressive disorder. Zahedan J Res Med Sci 2014; 16: 29–31.
11.
A-Tjak JGL, Davis ML, Morina N, Powers MB, Smits JAJ, Emmelkamp PMG: A meta-analysis of the efficacy of acceptance and commitment therapy for clinically relevant mental and physical health problems. Psychother Psychosom 2015; 84: 30–36.
12.
Cuijpers P, van Straten A, Andersson G, van Oppen P: Psychotherapy for depression in adults: a meta-analysis of comparative outcome studies. J Consult Clin Psychol 2008; 76: 902–922.
13.
Tolin DF: Is cognitive-behavioral therapy more effective than other therapies? A meta-analytic review. Clin Psychol Rev 2010; 30: 710–720.
14.
Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56–62.
15.
DeRubeis RJ, Cohen ZD, Forand NR, Four­nier JC, Gelfand LA, Lorenzo-Luaces L: The Personalized Advantage Index: translating research on prediction into individualized treatment recommendations. A Demonstration. PLoS One 2014; 9:e83875.
16.
First MB, Spitzer RL, Gibbon M, Williams JBW: Structured Clinical Interview for DSM-IV Axis I Disorders, Clinician Version (SCID-CV). Washington, American Psychiatric Press, 1996.
17.
Beck AT, Rush J, Shaw BF, Emery G: Cognitive Therapy of Depression. New York, Guilford Press, 1979.
18.
Boelens W: Behandelprotocol/Depressie/deel therapeutenboek + werkboek, ed 1. Amsterdam, Boom Cure & Care, 2009.
19.
A-Tjak JGL: Acceptance and Commitment Therapy. Theorie en praktijk, ed 2. Houten, Bohn Stafleu Van Loghum, 2015.
20.
Hayes SC, Strosahl K, Wilson KG: Acceptance and Commitment Therapy: An Experiential Approach to Behavior Change. New York, Guilford Press, 1999.
21.
Zettle RD: ACT for Depression: A Clinician’s Guide to Using Acceptance and Commitment Therapy in Treating Depression. Oakland, New Harbinger, 2007.
22.
Robinson P, Strosahl KD: The Mindfulness and Acceptance Workbook for Depression: Using Acceptance and Commitment Therapy to Move through Depression and Create a Life Worth Living. Oakland, New Harbinger, 2008.
23.
Amtz A, Dreessen L, Schouten E, Weertman A: Beliefs in personality disorders: a test with the Personality Disorder Belief Questionnaire. Behav Res Ther 2004; 42: 1215–1225.
24.
First MB, Gibbon M, Spitzer RL, Williams JBW, Benjamin LS: Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID-II). Washington, American Psychiatric Press, 1997.
25.
Rabkin JG, Klein DF: The clinical measurement of depressive disorders; in Marsella A, Hirschfeld R, Katz M (eds): The Measurement of Depression. New York, Guilford Press, 1987, pp 30–83.
26.
Trivedi MH, Rush AJ, Ibrahim HM, Carmody TJ, Biggs MM, Suppes T, Crismon ML, Shores-Wilson K, Toprac MG, Dennehy EB, Whitte B, Kashner TM: The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR), in public sector patients with mood disorders: a psychometric evaluation. Psychol Med 2004; 34: 73–82.
27.
Rush A, Bernstein IH, Trivedi MH, Carmody TJ, Wisniewski S, Mundt JC, Shores-Wilson K, Biggs MM, Woo A, Nierenberg AA, Fava M: An evaluation of the Quick Inventory of Depressive Symptomatology and the Hamilton Rating Scale for Depression: a Sequenced Treatment Alternatives to Relieve Depression trial report. Biol Psychiatry 2006; 59: 493–501.
28.
Power MJ: Development of a common instrument for quality of life; in Nosikov A, Gudex C (eds): Developing Common Instruments for Health Surveys. Amsterdam, IOS Press, 2003, pp 45–63.
29.
Johnsen T, Friborg O: The effects of cognitive behavioral therapy as an anti-depressive treatment is falling: a meta-analysis. Psychol Bull 2015; 141: 747–768.
30.
Hedeker D, Gibbons RD: Longitudinal Data Analysis. Hoboken, John Wiley & Sons, 2006.
31.
Hox J: Multilevel Analysis Techniques and Applications, ed 2. New York, Routledge, 2010.
32.
van Ginkel JR, Kroonenberg PM: Analysis of variance of multiply imputed data. Multivariate Behav Res 2014; 49: 78–91.
33.
Cohen J: Statistical Power Analysis for the Social Sciences. Hillsdale, Erlbaum, 1988.
34.
Morris SB, DeShon RP: Combining effect size estimates in meta-analysis with repeated measures and independent-groups designs. Psychol Methods 2002; 7: 105–125.
35.
Morris SB: Estimating effect sizes from pretest-posttest-control group designs. Organ Res Methods 2008; 11: 364–386.
36.
Lappalainen P, Granlund A, Siltanen S, Ahonen S, Vitikainen M, Tolvanen A, Lappalai­nen R: ACT Internet-based vs face-to-face? A randomized controlled trial of two ways to deliver acceptance and commitment therapy for depressive symptoms: an 18-month follow-up. Behav Res Ther 2014; 61: 43–54.
37.
Barth J, Munder T, Gerger H, Nüesch E, Trelle S, Znoj H, Jüni P, Cuijpers P: Comparative efficacy of seven psychotherapeutic interventions for patients with depression: a network meta-analysis. PLoS Med 2013; 10: e1001454.
38.
Kwan BM, Dimidjian S, Rizvi SL: Treatment preference, engagement, and clinical improvement in pharmacotherapy versus psychotherapy for depression. Behav Res Ther 2010; 8: 799–804.
39.
Mergl R, Henkel V, Allgaier AK, Kramer D, Hautzinger M, Kohnen R, Coyne J, Hegerl U: Are treatment preferences relevant in response to serotonergic antidepressants and cognitive-behavioral therapy in depressed primary care patients? Results from a randomized controlled trial including a patients’ choice arm. Psychother Psychosom 2010; 80: 39–47.
40.
Davies C, Niles AN, Pittig A, Arch JJ, Craske MG: Physiological and behavioral indices of emotion dysregulation as predictors of outcome from cognitive behavioral therapy and acceptance and commitment therapy for anxiety. J Behav Ther Exp Psychiatry 2015; 46: 35–43.
41.
Wolitzky-Taylor KB, Arch JJ, Rosenfield D, Craske MG: Moderators and nonspecific predictors of treatment outcome for anxiety disorders: a comparison of cognitive behavioral therapy to acceptance and commitment therapy. J Consult Clin Psychol 2012; 80: 786–799.
42.
Bohlmeijer ET, Lamers SM, Fledderus M: Flourishing in people with depressive symptomatology increases with acceptance and commitment therapy. Post-hoc analyses of a randomized controlled trial. Behav Res Ther 2015; 65: 101–106.
43.
Ryff CD: Psychological well-being revisited: advances in the science and practice of eudaimonia. Psychother Psychosom 2014; 83: 10–28.
44.
Fava GA: Well-Being Therapy: Treatment Manual and Clinical Applications. Basel/New York, Karger, 2016.
45.
Garfield SL: Research on client variables in psychotherapy; in Bergin AE, Garfield SL (eds): Handbook of Psychotherapy and Behavior Change. Oxford, Wiley, 1994, pp 190–228.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.